Gene activity in the nose may signal lung cancer – Fox News

Genetic changes in the cells lining the inside of the nose might someday help doctors diagnose lung cancer, a recent study suggests.

"The idea that you don't have to sample the disease tissue but can diagnose presence of disease using relatively accessible cells that are far from the tumor . . . is a paradigm that can impact many cancers," Dr. Avrum Spira from Boston University School of Medicine, a member of the study team, told Reuters Health by email.

The layer of cells that covers the surfaces of the body and lines the cavities is known as the epithelium. Researchers found that distinctive changes in gene activity in the nasal epithelium of lung cancer patients closely parallel the changes seen in lung epithelium and can distinguish between benign lung disease and cancer.

"I think the most interesting finding was the genomic changes in the nasal epithelium of lung cancer patients mirror so closely those found in the lower airway," Spira said.

The researchers thought the nose would be "a reasonable surrogate for the 'field of injury' in the bronchial airway," he added, but the surprisingly strong concordance between the nose and lower airway gave them the encouragement to develop a nasal biomarker for lung cancer detection.

"Pulmonary nodules represent a growing diagnostic dilemma in the U.S. as we have started to screen for lung cancer," Spira said. "A nasal swab that is highly sensitive for lung cancer in this setting would enable physicians to avoid unnecessary invasive biopsies in nodule patients who are unlikely to have lung cancer."

Past research has found that gene expression profiles from normal bronchial epithelial cells can distinguish smokers and former smokers with lung cancer from individuals with benign lung disease, and that nasal and bronchial epithelium respond similarly to tobacco smoke.

Spira's team sought to determine whether cancer-associated gene expression in the nasal epithelium might be useful for detecting lung cancer in current and former smokers.

They identified 535 genes that had different activity patterns in the nasal epithelium of patients with lung cancer versus those with benign disease.

Cancer-associated gene changes correlated significantly between nasal epithelium and bronchial epithelium samples, and the genes that were more active in nasal epithelium of patients with lung cancer were among the genes whose activity was most increased in bronchial epithelium of patients with cancer.

When researchers compared models doctors might use to determine the likelihood of lung cancer, nasal gene activity was more accurate than clinical risk factors alone for diagnosing lung cancer, according to the Journal of the National Cancer Institute report.

The combination of clinical factors and gene activity score accurately predicted cancer 91 percent of the time, compared to 79 percent for the model based on risk factors. The combined model also had 85 percent accuracy differentiating lung cancer from benign disease, compared to 73 percent.

"One of the big-picture messages for physicians is that molecular tests like this one are emerging as part of precision medicine approaches for early cancer detection," Spira said.

See the rest here:
Gene activity in the nose may signal lung cancer - Fox News

Knowing what’s wrong can be a comfort – the Irish News


the Irish News
Knowing what's wrong can be a comfort
the Irish News
The centre, spearheaded by consultant in genetic medicine Dr Shane McKee, have been involved in the design and operation of the UK-wide Deciphering Developmental Disorders (DDD) Study since 2011. The DDD Study involves scientists sequencing the ...

The rest is here:
Knowing what's wrong can be a comfort - the Irish News

Genetic driver behind rare skeletal dysplasia condition found – Baylor College of Medicine News (press release)

Researchers in the Department of Molecular and Human Genetics at Baylor College of Medicine have identified a previously unimplicated gene behind a particular form of chondrodysplasia, a skeletal dysplasia that affects cartilage formation and causes disproportionate short stature and premature osteoarthritis. The study appears in the Journal of Clinical Investigation.

Stemming from research being performed at Baylor and its genetics department as part of a systematic search for genetic causes of skeletal dysplasias, the project set out to identify the genetic driver behind Shohat type spondyloepimetaphyseal dysplasia (SEMD). It was led by Dr. Brendan Lee, professor and chair of molecular and human genetics at Baylor, and a team of researchers including project leader Adetutu Egunsola, a genetics graduate student.

SEMD is a rare type of skeletal dysplasia that impacts the development of cartilage and results in a form of dwarfism, characterized by a particular pattern of joint abnormalities, scoliosis and defects of the long bones.

Through combined whole exome sequencing and studies in zebrafish and mice, Lee and his team were able to identify a completely new gene associated with this skeletal dysplasia, DDRGK1, and discovered how it functions in cartilage. In zebrafish, for example, a DDRGK1 deficiency disrupts craniofacial cartilage development and causes a decrease in levels of the protein SOX9.

Not only did we discover the requirement of DDRGK1 in maintaining cartilage, but we also found that it to be a regulator of SOX9, which is the master transcription factor that controls cartilage formation the human skeleton, said Lee, who also holds the Robert and Janice McNair Endowed Chair in molecular and human genetics. If you do not have the SOX9 protein, you do not have cartilage it drives the production of cartilage in growth plates and joint cartilage all over the body.

The relationship between DDRGK1 and SOX9 reveals a novel mechanism that regulates chondrogenesis, or cartilage maintenance and formation, by controlling SOX9 ubiquitination, a process that controls the degradation of proteins like SOX9. Loss of the function of DDRGK1 causes this cartilage dysplasia in part via accelerated destruction of SOX9.

Studying this skeletal dysplasia resulted in the biological insight about this gene that had never been implicated in any disease condition related to the skeleton, Lee said. The future is to find out whether DDRGK1s function more globally controls ubiquitination in general and to determine how this process could be targeted for treating patients with dwarfism.

Other contributors to this work include Richard Gibbs, Adetutu T. Egunsola, Yangjin Bae, Ming-Ming Jiang, David S. Liu, Yuqing Chen-Evenson, Terry Bertin, Shan Chen and James T. Lu with Baylor, Nurit Magal with Rabin Medical Center, Annick Raas-Rothschild with Sheba-Tel Hashomer Medical Center, Eric C. Swindell with the University of Texas Graduate School of Biomedical Sciences, Lisette Nevarez and Daniel H. Cohn with the University of California, Philippe M. Campeau with the University of Montreal and Mordechai Shohat with the Sackler School of Medicine at Tel Aviv University.

This research was supported by the BCM Intellectual and Developmental Disabilities Research Center and a Program Project grant from the Eunice and Kennedy Shiver National Institute of Child Health and Human Development, the BCM Advanced Technology Cores with funding from the NIH, the Rolanette and Berdon Lawrence Bone Disease Program of Texas, the BCM Center for Skeletal Medicine and Biology and Tel Aviv University.

Originally posted here:
Genetic driver behind rare skeletal dysplasia condition found - Baylor College of Medicine News (press release)

Synchrotron sheds (X-ray) light on carbon chemistry at ocean … – Science Daily

Nature's carbonate system, the dynamic chemistry involving carbon dioxide (CO2), carbonate (CO32-), bicarbonate (HCO3-), and carbonic acid (H2CO3), is a vital component of the biosphere. Carbonate, bicarbonate, and carbonic acid emerge when atmospheric carbon dioxide dissolves in the oceans, which is the largest sink for this greenhouse gas. Researchers are interested in better understanding the carbonate system to potentially help facilitate carbon sequestration schemes, especially with carbon-bonding minerals, to help mitigate climate change. The carbonate system is also central to biological respiration systems, another reason why researchers are interested in this chemistry.

Recently, a group of chemists from the University of California, Berkeley teamed up with scientists at Lawrence Berkeley National Laboratory (LBNL) and made breakthrough discoveries about the carbonate species' behavior at saltwater surfaces, like that of the ocean. They report their findings this week in The Journal of Chemical Physics, from AIP Publishing.

According to one of the paper's authors, UC Berkeley chemistry professor Richard Saykally, a strong motivation for this research was understanding the chemical processes involved in carbon sequestration. They found that while neutral carbonic acid was most heavily present at the surface, as was expected, the more highly charged carbonate ion was more abundant than the weaker bicarbonate.

"We want to generally advance our understanding of the global carbon cycle," Saykally said. "The aspects of this cycle that we have been focusing on begin with carbon dioxide in the atmosphere dissolving into salt water, followed by some very interesting chemistry."

Carbon dioxide is captured by the water surface and hydrated to form carbonic acid or bicarbonate, which can then ionize into either bicarbonate or carbonate where carbonate may react with dissolved magnesium or calcium ions to form limestone.

"We want to know all those steps going from gaseous carbon dioxide in the atmosphere to limestone," Saykally said. "Our goal is to understand all the details in all the steps in that process."

UC Berkeley chemistry doctoral candidate Royce Lam, a co-author of the paper who led much of the research, wanted to build on earlier examinations of the hydration structure of carbonic system species, focusing on the relative abundances of carbonate species at the liquid surface.

Collaborating with LBNL's Dr. Hendrik Bluhm, Lam and co-authors made use of the ambient pressure photoemission spectroscopy (APPES) beamline (11.0.2) at the Advanced Light Source synchrotron at LBNL, to conduct X-ray photoemission spectroscopy (XPS) measurements -- a way to probe the molecular makeup of materials using an intense beam of high-energy X-rays. The XPS system enabled them to probe different aspects of the carbonate system they could not access before.

"What is special about XPS is that it allows us to probe at different depths into the water surface," Lam said. "This is one of the few beamlines in the world that can do this class of experiments on liquids."

For samples, Lam combined solutions of the carbonate species and hydrochloric acid, which fortuitously resembled the ocean system. With a liquid microjet device, the researchers injected these samples into a vacuum chamber and probed them at multiple X-ray energies to deduce the relative abundances of the carbonate species from the photoemitted electrons.

At the liquid surface, both carbonate and carbonic acid were more abundant than biocarbonate. The most significant surprise was that the more highly charged carbonate was more abundant at the surface than the less charged bicarbonate, which conflicts with expectations from existing theoretical models.

This raises important question about where the bicarbonate could be moving in the system, with a possibility that the carbonate could be "ion pairing" with sodium, changing the chemistry, and causing bicarbonate to move to lower depths.

"We are still working on the theory and we hope that this paper will stimulate further theoretical discussion that may actually yield definitive insights about what is going on here," Lam said.

Lam hopes that this research will also lead to more direct research on carbon sequestration possibilities.

"So, the next step would be to look further into ion pairing, and essentially limestone or mineral formation, specifically, looking at the interaction of calcium and magnesium ions with carbonate," Lam said of one carbon sequestration possibility he discussed.

Saykally feels this research connects with the whole system of aqueous carbonate chemistry, with applications ranging from carbon sequestration to biomedical research.

"In order to achieve these kinds of advances, I believe you have to know every detail of the chemistry involved in all those steps of the water-carbonate system." Saykally said. "It is a very intricate chemistry with profound practical implications."

Go here to see the original:
Synchrotron sheds (X-ray) light on carbon chemistry at ocean ... - Science Daily

Quantum Microscope Spies on Chemical Reactions in Real Time – Scientific American

A quantum microscope that uses a sensor built from diamonds could allow researchers to study such nanoscale mysteries as how DNA folds in a cell, why drugs work or how bacteria metabolize metals. Crucially, the microscope can image individual ions in a solution and reveal biochemical reactions as they occurwithout interfering in the process. The team behind the system described the results in a February 14 preprint on the arXiv server.

Researchers have long wanted an imaging system for molecular structures that works like hospital magnetic resonance imaging (MRI) machines, which reveal structures inside the human body without harming them. The idea behind a quantum MRIwhich images at the quantum level using electron spinsis to do the same for chemical reactions including those involving metal ions. Current magnetic resonancetechniques can only reveal structures measuring 10 micrometres or more, and the only way to detect metal ions inside a cell is to add reactive chemicals or freeze the cell so it can be imaged under powerful microscopesprocedures that kill the cell.

A hospital MRI machine works by placing a patient inside a magnetic field, such that protons in the body's atoms align with the machine's magnet. The machine then sends radio pulses through the body area being imaged, which knocks the protons out of alignment. When these pulses are switched off, the protons realign and emit electromagnetic waves at a particular frequency. If the frequency emitted by the body's tissues matches that of sensors in the machine, the two frequencies will resonate like guitar strings tuned to the same note. The machine uses this resonance to reconstruct an image of the body.

A team led by physicists Lloyd Hollenberg and David Simpson at the University of Melbourne, Australia, wanted to use this technique to detect metal ions in cells. Some metal ions can be harmful to cells, whereas others are necessary for biochemical reactions, such as those involved in metabolism. The catch is that an MRI sensor needs to be about the same size as the item being imaged, which is currently impossible when trying to look at a single atom.

To make their quantum MRI microscope, the researchers used 2-millimetre-wide diamonds that containedatomic-sized flaws in their crystal structure. These flaws are sensitive to changes in magnetic fields and can be 'tuned' to resonate with the spin of the molecule or ion that is being detected. When the diamond's flaws are illuminated with a green laser, the diamond fluoresces red, and the brightness of that fluorescence depends on the strength and direction of an applied magnetic field.

Hollenberg, Simpson and their colleagues used a diamond that had an array of flaws in specific locations just below its surface and placed it at the end of a microscope next to a sample. The researchers tuned the defects to a frequency that resonated with the spin of an ionized form of copper that is missing two electrons (Cu2+). By touching the diamond probe to the surface of a sample containing copper ions, the resonance between the two stimulated fluorescence in the diamond flaws. The researchers used a computer program to examine the colour coming off the diamond flaws and to reconstruct an image of the sample, revealing the precise location of each copper ion.

Next, the researchers flooded the sample with an acid that adds an electron to Cu2+, turning it into Cu+. As they added the acid, they imaged the sample and watched the Cu2+spin pattern disappear. The pattern then reappeared over the course of an hour as the sample was oxidized to Cu2+on exposure to air. Such a method could one day allow researchers to watch biochemical reactions as they occur in cells.

Because the method is non-invasive, it could theoretically be used to image the interior of living cellssomething that Simpson and Hollenberg's team is working towards. The main obstacle is that the diamond probe needs to be physically close to the sample to produce a signal. But the team says that the current method will still be useful for understanding drug mechanisms and investigating proteins found on the cell membrane. The researchers are also trying to adapt the system so it can detect different metals, including iron.

Friedemann Reinhard, a physicist at the Technical University of Munich in Germany, praises the work. The innovations here bring it a lot closer to the application, he says. His group is also working with diamond microscopy, creating a system that could image molecules in 3D.

He adds that although the new technique still needs improvements, such as the ability to find copper ions in low-concentration solutions, it is definitely a great step ahead.

This article is reproduced with permission and wasfirst publishedon March 6, 2017.

Read the original:
Quantum Microscope Spies on Chemical Reactions in Real Time - Scientific American

Lakewood Ranch basketball tasked with redeveloping chemistry – YourObserver.com


YourObserver.com
Lakewood Ranch basketball tasked with redeveloping chemistry
YourObserver.com
They have been the core of the team for two seasons so Schiller's challenge for next season will be creating the same chemistry among the players who will have to fill their roles. The good news for Lakewood Ranch is next year's team will include Evan ...

Excerpt from:
Lakewood Ranch basketball tasked with redeveloping chemistry - YourObserver.com

Associate chemical engineering professor recognized by The Welch … – UT The Daily Texan

The Welch Foundation, one of the largest funding resources for chemical research, recognized associate professor Delia Milliron for her contribution to controlling sunlight from entering buildings, according to the foundations website.

Last Wednesday, The Welch Foundation announced Milliron as one of the two recipients of the 2017 Norman Hackerman Award in Chemical Research. The award was established to honor Norman Hackerman, the foundations scientific advisory board member, with the purpose of supporting Texas scientists who are dedicated to increasing the fundamental understanding of chemistry.

Milliron said it is a great honor to be recognized by The Welch Foundation, and she is very proud to receive this award.

(The Welch Foundation is) a very important supporter of chemistry across the state of Texas, and they found some of the research in my lab and in many others across campus and around the state, Milliron said over the phone. Its a really important driver of innovation in Texas to have the Welch foundation supporting us with grants and with awards like this one.

Milliron is also an associate editor of Nano Letters, a journal of the American Chemical Society, which includes publications related to nanomaterial chemistry.

Thomas Truskett, chair of the McKetta Department of Chemical Engineering, said Milliron is a rising star in the chemical sciences, and she is well-deserved of the award.

The Hackerman Award is a fiercely competitive prize, Truskett said in an email. The fact that Dr. Milliron was chosen for it this year, as well as another colleague from our Department last year, points toward the excellence of our young faculty, who represent the future of the Department.

The Welch Foundation is based in Houston and has contributed to the advancement of chemistry by supporting institutions in Texas with research grants and special projects, according to the foundations website.

Chemistry freshman Andrea Torres said its inspiring to see Millirons recogniton, because she represents a strong female leader in the scientific community.

For a long time chemistry and sciences in general were predominantly male, and to have a woman win an award like that its a pretty big deal, Torres said. It shows that we have a program thatpushes innovation.

Read the original here:
Associate chemical engineering professor recognized by The Welch ... - UT The Daily Texan

Good chemistry is important for good fudge and good business for this mom and daughter operation in Bethany – kfor.com


kfor.com
Good chemistry is important for good fudge and good business for this mom and daughter operation in Bethany
kfor.com
For much of the past 4 years the alchemy of fudge has been her chief area of study, a huge departure from her past studies in law and teaching law at the university level. "I needed something that would give me some flexibility," says Annette. Okay, so ...

Read more:
Good chemistry is important for good fudge and good business for this mom and daughter operation in Bethany - kfor.com

Clarkson University appoints professor of chemistry and biomolecular science – North Country Now

Jiayin Yuan was recently appointed associate professor of chemistry and biomolecular science at Clarkson University.

Yuan received his bachelor of engineering degree in applied chemistry from Shanghai Jiao Tong University, P. R. China, his master of science in macromolecular chemistry from the University of Siegen, Germany, and his Ph.D. in polymer chemistry, graduating summa cum laude, from the University of Bayreuth, Germany.

Before coming to this position, Yuan did research in polymer/colloid/materials chemistry at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany.

He has teaching experience as an associate faculty member of the International Max Planck Research School and at the University of Potsdam, where he completed his habilitation in 2015, according to a press release from Clarkson.

His recent honors include receiving the Otto-Warburg Award, the Max Planck Society Postdoc Fellowship, the European Research Council starting grant award, the Dr. Hermann-Schnell Award of the German Chemical Society and the Dozentenpreis des Fonds from the Foundation of the German Chemical Industry, the release said.

Yuan has organized scientific gatherings and presentations in Europe as well as the United States. He has published about 120 articles and five book chapters, and has been guest editor and served on editorial boards of professional journals. He also has provided referee service for journals and funding agencies.

He has presented his work in many countries, including Germany, France, Poland, Switzerland, Belgium, China, Sweden, the United Kingdom, and the United States.

View original post here:
Clarkson University appoints professor of chemistry and biomolecular science - North Country Now

Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock – Investorplace.com

The biotech industry had a rough 12 months. First the beatings came from presidential hopeful Hillary Clinton as she vowed to crush their pricing models. Now President Donald Trump is following up with similar promises.

For a long while, tickers like the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) were toxic to investors. The thesis was that healthcare and biotech companies were untouchable with the political cloud looming above them.

Recently, and in spite of the fact that that nothing has changed from the political standpoint, the worrisome headlines became stale and lost their zing. Thats what usually happens. Traders initially over-react to the headline and then after a while, return to trading the fundamentals.

The companies in the IBB have legitimate, viable businesses. This is a classic case of a bad apples who spoil the bunch.

Technically the IBB stock price is in a breakout that I rode higher on Feb. 11 with debit call spreads.

The important price action came when the IBB reclaimed the $280 per share pivotal zone. From here at the $300 per share level, it can once again provide a base from which to mount another leg higher. This area is an important long term pivot level so has the potential to be a solid base once it is cleared.

Click to Enlarge The ongoing IBB measured move has more upside potential, but there is also resistance looming above. Whats important to me as a premium seller is to find areas where price is not going so I can safely sell risk for income.

Now that Wall Street is repricing the IBB where it should be in spite of the headlines, I want to sell downside risk.

Finding the right level can be tricky. Biotech companies are susceptible to big moves on surprise headlines. Even though the IBB risk is spread among its components, they tend to trade in unison. So if one component of the IBB moves on a headline, the rest would follow in sympathy. This makes trading IBB via sold premium as risky as a single momentum headline stock.

The Bullish Trade: Sell the IBB Jan 2018 $255/$250 credit put spread. I collected $1 per contract to open which would be a 25% yield on risk if I win. The 15% price buffer gives this trade an 85% theoretical chance of success.

Usually I like to hedge my bet. In this case I will sell opposite risk so to balance the trade. There is no rush to do so in this uber-bullish markets. So I could delay entry until I see an abatement in the exuberance over biotech stocks.

The Hedge (optional): Sell the IBB Jan 2018 $355/$360 credit call spread. I collect an additional $1 per contract to open.

If I take both sides then I would be in a sold iron condor where I need IBB to stay between $255 and $355 per share. If IBB stays in the range, this trade would yield over 60% on money risked.

I am not required to hold my options trades open through expiration. I can close either at any time for partial gains or losses.

Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him on Twitter at @racernicand stocktwits at@racernic.

More:
Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock - Investorplace.com

iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads – Investorplace.com

By Serge Berger, Head Trader & Strategist, The Steady Trader|Mar 7, 2017, 8:02 am EST Popular Posts: Recent Posts:

Biotechnology stocks as represented by theiShares Nasdaq Biotechnology Index (ETF)(NASDAQ:IBB) have rallied 13% year-to-date. Thats notable considering that over the past 12 months, the IBB ETF has only rallied by about 14%.

Many traders in recent days have pointed to the continued strength in biotech stocks as a sign that the broader market is not yet ready to roll over. But it is notable that the IBB, as a result of the recent rally, has now reached an important technical level on the charts that may offer better technical resistance.

A simple yet effective trick that I repeatedly use to gauge the internal strength of the broader stock market is by checking the pulse of the so calledrisk-on groups. While these groups change over the years, they often include technology and financial stocks. In recent years, biotech, tech as a whole and small-cap stocks, among others, have led the risk-on pack.

Over the past few weeks, biotech stocks and the IBB ETF have showed both absolute and relative strength versus the broader stock market. Through this lens, one could argue that it is premature to get too defensive on the stock market in the near-term and possibly the intermediate-term until biotech stocks begin to back off some.

When I last discussed the state of biotech stocks on Feb. 1,I offered that the IBBs bullish reversal from Jan. 31 could be the beginning of a next swing higher with price targets in the$285-$290 area. Two weeks later, the upper end of this price target had been reached, and last week the IBB ETF further extended this rally into the $300 level.

Now, lets look at the charts.

On the multiyear weekly chart, we see that this recent rally has brought the IBB back to the very upper end of a sideways channel, which now also lines up with the 100-week simple moving average (blue).

Click to Enlarge

This confluence of technical resistance around the $300 area could provide a more meaningful challenge to be overcome.

Next Page

Article printed from InvestorPlace Media, http://investorplace.com/2017/03/ishares-nasdaq-biotechnology-index-etf-ibb-is-at-a-crossroads/.

2017 InvestorPlace Media, LLC

Follow this link:
iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads - Investorplace.com

Student profile: Keegan Mendez – Harvard School of Engineering and Applied Sciences

This sky-diving, squash-playing, thrill-seeking student is gearing up for her next great adventurein biomedical engineering research and discovery.

Why did you decide to concentrate in biomedical engineering?

As a child, I always had a love of math and science, and I liked to use my hands to create thingsI shunned Barbie dolls for building blocks. I was already a math and science nerd, but what appealed to me about bioengineering specifically is the breadth and diversity of research options, from organs on a chip to medical device design, and everything in between. The research that is happening right nowlike trying to grow a human heart outside the bodyis so cutting-edge and exciting.

Tell us about some of the bioengineering research youve had the opportunity to conduct at SEAS.

During my sophomore year, I began working in David Mooneys lab on developing the TheraCardium, which is a cardiac device for stem cell delivery to the heart for patients who have suffered a heart attack. The device supports regrowth of the damaged tissue and helps to prevent scarring of the dead heart muscle, in an effort to help prevent future cardiac events.

Mendez works on a biomedical research project in the Mooney lab. (Photo by Eliza Grinnell/SEAS Communications.)

Why was that research experience beneficial for you?

By working on that project, I experienced many different types of research, from preclinical studies in animals, to tissue engineering, to the materials science involved in building the device, to various soft robotic manufacturing techniques. I had the opportunity to work with many new technologies that I hadnt been exposed to in the classroom.

What is the topic of your senior thesis project?

Drawing on my work on the TheraCardium, I am designing a soft robotic drug delivery system. The device involves a hydrogel adhered to a soft robotic balloon that could be placed on the surface of the heart to directly delivery therapy to the muscle. Inflation of the balloon stretches the mesh size of the hydrogel, enabling delivery of the drug encapsulated within the hydrogel. By controlling the balloon inflation, we can achieve radio control, or the ability for on-and-off delivery. The device could also incorporate multiple balloons, delivering different drugs to separate areas of the heart.

In addition to your academic and research success, youve also served as co-captain of the Harvard Womens Squash team. How did you get involved with that sport?

I started playing squash competitively when I was 8 years old. The neighborhood where I grew up had one of the best junior squash programs in the country. I was inspired by my older sister, Haley, who is a great squash player. She was recruited to play squash at Harvard. When it came time for me to apply to college, the coach told me he had used all his recruiting spots, but if I could get into Harvard, I could play, too. It all worked out, and Ive been on the team for the past four years. There is a big mental aspect to squash. Your tactics and shot selection become critically important at the college level, since all the players are very technically proficient.

Are you and your older sister squash rivals?

Were a very competitive family. When we play board games, it gets so competitive it is almost scary. Haley has always been better than I was on the squash court, but we still play all the time. We are definitely competitive academically, as well, and while I love squash, I feel like my true passion lies in academics.

When playing squash at the college level, tactics and shot selection become incredibly important, Mendez said. (Photo by Eliza Grinnell/SEAS Communications.)

Do you think academics will play a role in your future plans?

Definitely. I am planning to apply for Ph.D. programs in bioengineering, and Harvard is my first choice. Ive been really excited about the research Ive been able to do as an undergraduate, and I want to continue contributing to science and advancing the field. The projects Ive been working on are just so cool, and I want to keep my research momentum going.

How do you feel that SEAS has prepared you for your future?

Beyond learning the technical skillslike how to code and use machinesbeing able to work closely with my peers on teams has given me a lot of confidence. As an engineer, you need to be able to communicate ideas effectively to people who may not be engineers. Collaboration is key within engineering, with each team member contributing an important piece to the puzzle. I have also been humbled, and learned when to ask for help, when to seek out peers, and when to work collaboratively in groups as opposed to attempting to do everything myself.

Follow this link:
Student profile: Keegan Mendez - Harvard School of Engineering and Applied Sciences

Anatomy Of A Takedown: William F. Buckley Jr. Vs. George Wallace – WBUR

wbur Commentary National Urban League President Vernon Jordan Jr., left, and William F. Buckley Jr., host and inquisitor of the public television show Firing Line, find something to laugh about at the 15th birthday celebration of the show in New York, Tuesday, Feb. 25, 1981. Jordan was one of 48 guests on the show who had come to celebrate with Buckley. (Kaye/AP)

Now that congressional Democrats have settled on legislative total war on Trump, some progressives are worried the artillery is wreaking collateral damage on the presidents working-class base. [D]emocrats often sound patronizing when speaking of Trump voters, demonizing them along with their disdain-deserving leader, lamentsNew York Times columnist Nicholas Kristof.

For an example of what concerns him, check out the comments thread to a recent Cognoscenti column urging empathy for the president and his backers. A progressive backlash against preaching empathy for Trump is unsurprising; the anger in some comments against the uneducated people and forgotten men supporting him is something else. In a polarized era of neighbors, family members and protesters screaming at each other over Trumpism, another writer asserts, There is little doubt about our need to find language that illuminates the dark abyss separating those who approve of our new presidents words and executive orders and Cabinet appointments from those appalled by them.

...you might askwhich words should be weaponized to resist an anti-immigrant, anti-environment, anti-safety netchief executive, andshould they be fired at his supporters as well?

If youre in the latter camp, as I am, you might askwhichwords should be weaponized to resist an anti-immigrant, anti-environment, anti-safety netchief executive, andshould they be fired at his supporters as well? To answer this, I found an instructive model from a half-century ago, when another populist double-talker was confronted by a famous wordsmith.

In January 1968, William F. Buckley Jr. featured segregationist Alabama Gov. George Wallace on Buckleys "Firing Line" interview show. You couldnt have paired an odder couple: Buckley, the Yale-educated, sesquipedalian guru of modern conservatism, and Wallace, the farmers son whod futiley blocked the schoolhouse door five years earlier against black students at his states university. The mens' dust-up, broadcast as Wallace readied a third-party presidential bid, today plays like a toned-down foretaste of the long-runningpublic television program "The McLaughlin Group," with repeated interruptions and efforts to out-snark one another. (Said asmiling Buckley:Youre telling me stuff that I knew when I was 3 years old, governor.)

The program, archived byStanford Universitys Hoover Institution, corroborates the observationthat Wallace was Trump before Trump becameTrump, down to the surly, just-bit-into-a-lemon grimaces at what he calls the pseudo-intellectual Buckley. The latter, coolly, sometimes self-deprecatingly, but relentlessly swatting Wallaces denials of racism, was, admittedly, a problematic defender of racial equality. In 1957, hed suggested that the white South was entitled to thwart African-American aspirations ...because for the time being, it is the advanced race. Like Wallace, Buckleyopposed the 1960s civil rights legislation, a stance hed recant years later.

Destiny, if not Buckley, intended for the Wallaceinterview to beredemptive (the hosts stated goal was to expose Wallace as a non-conservative, not rehash his renowned racial views).

Ive never said that you should have segregation of the school system or any other, Wallace said.

What steps did you take to encourage the enfranchisement of the Negro back before the [federal] government got on your back?" Buckley countered. " Its a clear part of the historical recordthat the South not only didnt encourage its Negroes to vote, but encouraged them not to vote.

In another exchange, when Wallace defended his home region as more law-abiding than the North, Buckley parried that southern law enforcement techniques were, to say the least, unusualthe Ku Klux Klan, for instance...

What does this decades-old brawl teach us about handling Trump? The lesson for liberals seething at the president is that there are more ways to skin a strongman than just venting rage. As necessary as the outrage-fueled mass protests against Trump are, Buckley shows how calm reason andhumor can also dismantle a foe. Anger can go too far; smart liberals know that actions such as blocking Education Secretary Betsy DeVos from visiting a school only sink toTrumps puerile incivility and risk turning off some people who might be open to theirviewpoint.

For their part, Trump voters must understand that theydont get a pass just because theyre genuinely pissed. Wallaces voters sincerely feared their ebbing white privilege; Buckley still called out collective Dixie racism. Today, its fair game to note the data showing that too many Trump supporters are indeed bigots, their Wallace-like disclaimers notwithstanding.

Of course, they're not all bigots.Kristof reminds us that some Trump folks voted for Barack Obama. But their support is even more confounding.If Trump is a con man peddling preposterous promises (Mexico will pay for that wall; Obamacare can be replaced with equal but cheaper coverage; climate change is a dismissible hoax), how gullible can his voters be?

...it's fair gameto hold a reality-reflecting mirror to Trump's supporters when their views are abhorrent or just plain ignorant, as Buckley did with segregationists.

Democratic discourse depends on a common frame of reality among citizens of differing views. I spoke to one pro-Trump friend during the campaign, trying to understand her politics, only to find they relied on half-truths and misinformation.Buckley was right: The voters blow it sometimes, as he said in the Wallace interview.

Should the opposition emulate Trumps rudeness?No.But it's fair gameto hold a reality-reflecting mirror to Trump's supporters when their views are abhorrent or just plain ignorant, as Buckley did with segregationists.

Wallace found the KKK remark insulting to his people. It certainly was. But below-the-belt? I doubt African-Americans living under Jim Crow would have thought so.

Follow Cognoscenti on Facebook and Twitter, and sign up for our twice-weekly newsletter.

Rich Barlow Cognoscenti contributor Rich Barlow writes for BU Today, Boston University's news website.

More

Read the original here:
Anatomy Of A Takedown: William F. Buckley Jr. Vs. George Wallace - WBUR

BJP hopes Modi chemistry will prevail over Congress-SP in Varanasi – Economic Times

VARANASI: The holy city Varanasi is not turning out to be the cakewalk the BJP might have hoped for its Assembly candidates in Prime Minister Narendra Modi's Lok Sabha constituency.

Factors like consolidation of opposition votes and well-entrenched rival candidates against BJP's perceived fumbling in picking its nominees have come together to make contests close in this high-profile seat.

BJP President Amit Shah might have dismissed opposition's suggestions that multiple public events by Modi here besides deployment of a number of union ministers and top party leaders in campaigning is indicative of "desperation" in his ranks but it is clear that his party is going out of the way to ensure a good saffron show.

"I am a little critical. There is an excess effort from the BJP and people can feel it. Everybody has a role and stature and I think it (Modi's numerous events) diminishes the prime minister's chair," said Ashok Kumar Upadhyay, a professor in Political Science Department of Banaras Hindu University.

He, however, told that the overdrive may end up helping the saffron party by winning over floating voters who are guided by the "wave".

The BJP had won three of the five seats falling in the Varanasi parliamentary constituency in 2012 and has changed two of the three winners this time round.

Neelkanth Tiwari is making his electoral debut replacing seven-time MLA Shyamdev Roy Chaudhari in Varanasi South seat and Saurabh Srivastava takes the baton from his mother Jyotsana Srivastava in Varanasi Cantonment. Both changes have not gone down well with sections of party cadres.

The party leadership has worked overtime to placate Chaudhari, well-regarded for his affability and accessibility, with Shah reaching out to him.

The change in Cantonment has invited allegations of dynasty politics as the Srivastava family has long held the constituency and even Saurabh Srivastava's late father was an MLA before his mother stepped in his shoes.

In Varanasi North, Muslims are in substantial numbers and have rallied around the Samajwadi Party-Congress candidate and former MLA Abdul Samad Ansari.

Ravindra Jaisawal of the BJP had won from here by a narrow margin and the combined votes of the two alliance partners has made matters difficult for him.

Read the original here:
BJP hopes Modi chemistry will prevail over Congress-SP in Varanasi - Economic Times

Anatomy of an Error: Fazio & Mertens – Chiesa Di Totti

We have all quite rightly marveled at the rebirth of Federico Fazio this season. After bouncing between Spurs and Sevilla prior to moving to Roma, the accepted wisdom was that Fazio was just another in a long name of players long on talent and short on results. Based on his statuesque figure and technique, Fazio profiled as the ideal, albeit it a bit slow, centerback; one who could be the foundation upon which your backline was built.

For a variety of reasons, it took Fazio several years and several more changes of sceneries to put it altogether. Fortunately for us, Roma has been the beneficiary of that latent development, as Fazio has been, without a doubt, one of the best defenders in Serie A this season, so please do not take what follows as an overarching critique of Fazios abilities nor a harbinger of bad things to come. He simply goofed up, as well all do, and its been such a long time since weve dissected an individual play, I thought it might be interesting to analyze exactly what went wrong.

First up, the goal in total

As we discussed yesterday, this goal was partially a product of Fazios error mistiming Marek Hamsiks final pass, but as with most things, that only tells a portion of the story. First, Roma had to turn the ball over, then they failed to dispossess Napoli in the middle third, and lastly, and I would argue most egregiously, they gave Hamsik WAY TOO MUCH space to make that pass. It was simply a sequence of poor decisions and poor execution.

However, with all that in mind, the most visible error here was Fazios ill-timed and somewhat unnecessary attempt to intercept that pass and/or cut off the passing lane, so lets take a look at that sequence.

The thing Id like you to take notice of, besides Mertens breezing past the last link in Romas defense, is just how soon Fazio jumped on this pass. Notice how he breaks towards, and really past, Mertens before Hamsik even receives the ball. And yes, had he picked off the pass wed be hailing his aggressiveness and timing, I get that, but in this instance, with no one behind him or directly on Mertens hip, Fazios speculative attempt at stealing the ball was haphazard and completely ill advised.

Here it is in freeze frame:

At this point, Daniele De Rossi is close enough to Mertens to corral or at least obscure his path a bit, while also allowing Juan Jesus to close the gap on the left, making Fazios jump all the more hasty. Granted the angle of this photo may be misleading, but the point was simply this: Fazios gamble was completely unnecessary, had he simply held his ground and even allowed the pass to make it to Mertens, Fazio would still have been in position to make a tackle or at least commit a necessary and justified foul, and, as we mentioned, DDR and Rruan werent so far away they couldnt have closed Mertens down had Fazio held his ground

As it stood, Fazios gamble was ill-advised and poorly executed, he made a decision when he didnt have tohis choice to try and jump that passing channel ceded control to Mertens. If he held his ground, Mertens would have had to make the decision, not Fazio, and as we mentioned, with De Rossi and Juan nearby, had Fazio held firm, Mertens path to goal would have been virtually non-existent....but check this out:

Thats how agonizingly close Wojciech Szczesny was to actually saving this; a few centimeters and a couple fractions of a second. Football is nothing if not a game of inches.

Ultimately, this was a team error. From the poor play out of their back, to their inability to stop Napolis counter, down to Kostas Manolas keeping Mertens on side, this was a prime example of how a series of seemingly innocuous decisions or indecisions can doom you during a 90+ minute match.

So while Fazios error was the most glaring, he was by no means the lone culprit. And the mere fact that we can be so pedantic about his performance shows just how far he has come this season. However, as we so often warn, with the margins for error razor thin, moments like these can be devastating and quite costly.

Also, apologies for the poor quality of some of those stills and gifs, I had trouble finding decent clips.

Visit link:
Anatomy of an Error: Fazio & Mertens - Chiesa Di Totti

Q&A: House on team chemistry, analytics – MLB.com

House's insight into athletic success has allowed him to not only impact baseball, where he currently works with many of the game's top pitchers, but also to extend his efforts into college football and the NFL.

House is the subject of this week's Q&A:

MLB.com: How did you become so involved in the football world?

House: When we first started doing motion analysis, we captured any movement we could capture. We have Dan Marino in the computer. We have Joe Montana, Steve Beuerlein. Remember Todd Marinovich, robo quarterback? We had a bunch of elite quarterbacks captured. All the data measured, but I didn't know what we were looking at. Then obviously we threw footballs in a baseball environment when I was a coach in the Padres' system and at the big leagues with the Rangers. I got that from the trainer in San Diego, Dick Dent. He figured out you have to have proper throwing mechanics to throw a spiral.

MLB.com: But that was taking football to baseball. Where, along the line, did you get involved in dealing with the football players?

House: Cam Cameron was the offensive coordinator with the San Diego Chargers, and I had been working with his boys in baseball. Both his sons pitched. Drew Brees was his quarterback. He said, "You know, do you think you might be able to talk to Drew?" I worked with him for about a year and a half. Then in the last game of his tenure with the Chargers, he blew his shoulder out really bad. He dislocated the right shoulder and suffered a 360-degree tear of the rotator cuff and labrum.

Dr. [James] Andrews put him back together, but didn't think Drew would ever throw a professional pass again. I got seriously involved with the rehab, and one thing leads to another. Nine months later, he signed with the Saints. And as they say, the rest is history. In sports, the word of mouth has an impact. I started with Drew, and one day another quarterback showed up, and all of a sudden I'm working with six or seven guys. Over the last four years, we've been working with 26 of the No. 1 quarterbacks in the NFL, a bunch of backups and most of the elite college quarterbacks.

MLB.com: I guess it's that old saying about timing. You were considered the nutty professor with the Rangers back in the 1980s, but you are readily accepted in the new century in the NFL.

House: Somebody's got to take a shot at being first. I've always been looking for a better way. It's finally starting to pay off. The really cool thing is we've figured out that rotational athletes -- hitters, golfers, tennis, football, softball, baseball -- are pretty much the same animal. The preparation and the movements are all really, really close. If you can teach pitching, you can teach quarterbacking. If you can teach quarterbacking, you can teach the physical movements and the physical preparations to hit like tennis, whatever. It got kind of easy once we started looking at the analytics of outcome and moving back to the process.

MLB.com: The process?

House: Sports are all about outcomes. You get contracts and big money if you're a pro guy because of outcomes. You get college scholarships because of outcome. The analytics out there are really good for that, but the confidence intervals and the standard deviations when you're measuring outcome aren't as good as when you're measuring process. Our confidence intervals and our standard deviations are more measurable, more quantifiable and more defendable than what the analytics guys are doing. Analytics are really good. We're just a little bit more predictable, because we're measuring process, not outcome.

We do movement analysis. We do functional strength. We do nutrition and sleep, and we do mental emotions. I was doing that with the Rangers. We've just gotten better and better and better working with the process, not the outcome.

MLB.com: You were a pioneer in analytics.

House: I was fortunate to run across Craig Wright. We did a book, "Diamond Appraised." We actually preceded Bill James and all those guys. We really didn't know what we were doing. Timing is everything. I just happened to be sitting at the bus stop when three dimensional motion analysis showed up, wireless CMG, sleeping monitor, what muscles were doing. Then obviously I went to school and got my Ph.D. in psychology and a master's in nutrition. It was just pretty much luck of the draw. Blind squirrels find an acorn.

MLB.com: Did it ever get frustrating that you had such a hard time being accepted with what's now commonplace?

House: It frustrated me that I wasn't a good enough communicator to make people understand the value involved with what we were doing. There were times when I had my feelings hurt, but it didn't stop me from pushing, because I knew we were doing something that was measurable and quantifiable for the first time in sport. That held me together.

MLB.com: What about how the human element plays into it? That's one thing that people seem to lose some sight of.

House: We're genetically predisposed for affiliation and failure. We are born with overwhelming need to be affiliated with something, and we learn more from our failures than we do from our successes. Where people have trouble identifying team chemistry, it basically boils down to those two things: the affiliation process, we want to belong to something, a team, and if that affiliation returns positive, you stay affiliated. Then the failure side of the equation -- if you're with a team that doesn't embrace failure as part of the learning process, then the attachment of feelings to failure or success gets in the way of the process.

The perfect example is what the Patriots do. On their wall, when you walk in their locker room, it basically says three things: do your job, trust the process, trust your teammate. That's it. Think about this: When people go to the Patriots, who do you think reframes to be affiliated? The Belichick boys or the new guys? The new guys. When you go to the Patriots, no matter what your personality, Randy Moss or whoever.

That's what creates chemistry. Going to the Cleveland Browns right now, they really don't have a process the kids can hang their hats on, so they're going in with kind of a question mark on how affiliated they're going to be to the Cleveland Brown Way until there's either a pre-sold chemistry like Belichick has, because his process is proven to everybody it works. Unless an organization can create a process that a player wants to be affiliated with -- and unless those players can reframe performance, success or failure, around that process -- they don't have chemistry.

MLB.com: Hal Keller used to say when he scouted amateurs he liked to see them have a bad day, because everybody fails at some point and the successful players deal with failure.

House: That's affiliation. Remember, you asked if I had my feelings hurt at the lack of acceptance 30, 40 years ago? I bought into the process I was involved with, not how it was being perceived. My value proposition was in my process, not the outcome of me being a great pitching coach or a great communicator or whatever. Eventually, if you're confident of your process and you have a belief system, your process is measurable, quantifiable and dependable, eventually it wins out.

MLB.com: As young player, how did you get so involved in the analytics aspect?

House: I never expected to play past college. When I left USC and signed with the Braves, I figured it was going be a real good summer job while I went ahead and got my Ph.D. I was pursuing baseball, living, breathing, dying baseball. That was my passion. But as a parallel process, I was in the classroom doing academics and research. Looking back, everybody had the same goals down, but they weren't talking to each other as they were approaching that goal. If I have a value to sports right now, it's connecting dots between different disciplines and making everybody aware that we all want to win the Super Bowl and we all want to win a Wor
ld Series, let's not be fractured with the process. Let's make sure we're all on the same page, so we have organizational process and team chemistry.

MLB.com: Is that exciting for you?

House: When I first started realizing how big the disconnects were in baseball, I didn't think there was any hope that I would see this in my lifetime, but now I do. The awareness now that there's a better way is starting to change throughout the game. I'm talking from Rookie ball to the Major Leagues, from the front-office analytics guys all the way down to the clubhouse. Other sports have figured it out a little quicker. Baseball's coming along, and it's going to be just fine. I've been involved in the game 50 years, and I'd like to think I carried the torch a little bit, and the kids that are standing on my shoulders now will take it home.

Tracy Ringolsby is a columnist for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.

Here is the original post:
Q&A: House on team chemistry, analytics - MLB.com

CBDual Biotechnology Corp. Announces the Completion of their … – Yahoo Finance

LOS ANGELES, CA / ACCESSWIRE / March 2, 2017 / CBDual Biotechnology Corp. ("CBDUAL") announced today the completion of the company's new clinical trial center in Southern California.

CBDual's new facility provides patients with easy access to participate in clinical trials of new medical cannabis medications, therapies, and products. CBDual will develop protocols to improve patient safety and data integrity in clinical research trials in compliance with the HIPAA.

The first scheduled trial will study the medicinal and therapeutic effects of CBD on oral health. The study anticipates between 1,000-2,000 patients and will test the effects of different CBD based mouthwashes and toothpastes.

CBDual has recently entered into a cross licensing agreement with Cavitation Technologies, Inc (OTCQB: CVAT; Berlin: WTC). This agreement covers intellectual property involving the application of technology and patented processes to produce high quality pharmaceutical grade cannabis materials with increased bio-availability and increased shelf life.

Dr. Greg Rubin, CEO of CBDual Biotechnology Corp., previously commented, "The improvement of consumer and medical products require the development of the best quality and utilization of the most innovative technologies in order to achieve ultimate results. The impact of the new clinical research brings us one step closer to introducing our new products to the US markets."

Recent breakthroughs in Cannabinoid (CBD) therapies and orally administered products prompt strong forecast for 2017. The Hemp Business Journal estimated that the CBD market will emerge as a $2.1 billion market in consumer sales by 2020. That represents a 700% increase from 2016. According to the National Institute on Drug Abuse, a number of studies have shown that CBD is a non-psychoactive cannabinoid and has a wide range of medical benefits, such as anti- inflammatory and anti-oxidant and many other health related benefits.

About CBDual Biotechnology Corp

CBDual Biotechnology is a privately held; US based Biotechnology Company with a proprietary technology for enhanced oral delivery of bioactive cannabinoids. This technology promotes good gums health and overall dental health due to higher effectiveness of the delivery methodology. Company was founded in 2016 and is headquartered in California with its R&D capability in Israel and Ukraine..

Website: http://www.cbdual.com/

About Cavitation Technologies, Inc.

Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, water treatment and cannabidiol processing. As an add-on to its existing neutralization systems, the company's patented Nano Reactor allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield.

Website: http://www.ctinanotech.com/ Follow us on Twitter: https://twitter.com/ctinanotech Like us on Facebook: https://www.facebook.com/ctinanotech

Forward Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions, and include statements regarding the anticipated installation and the timing of the installation, our intent to continue to focus on research and development, marketing and sales of our unique technology, our belief that our company is positioned for accelerated growth and the expected efforts to be made to enhance our shareholder's value. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Read More

Cavitation Technologies, Inc.

Contact:

Investor Relations Jessica Steidinger Jessica@ctinanotech.com Phone (818) 718-0905

SOURCE: CBDual Biotechnology Corp.

Continued here:
CBDual Biotechnology Corp. Announces the Completion of their ... - Yahoo Finance

Exploring Bioengineering and Communication Faculty and Students Present, Discuss Research – CSUF News

Cal State Fullerton faculty and students are presenting research on such subjects as bioengineering, broadcast journalism, free speech and communication styles at conferences and programs across the country. Among those delivering posters, papers and talks:

A research project conducted by Ashley Le-Pham while an undergraduate at Cal State Fullerton is among research projects that have been accepted for presentation at the April Posters on the Hill event in Washington, D.C. The program, established by the Council on Undergraduate Research, is an opportunity for select students from across the country to present their work before legislative leaders, federal agency program officers and the press.

Le-Pham 16 (B.S. biochemistry) will deliver Starch Bioengineering An Attempt to Combat Global Food Insecurity. Her faculty mentor was Christopher Meyer, professor of chemistry and biochemistry.

Brent Foster, associate professor of communications and interim director of undergraduate studies and general education, will present his paper Broadcast Armageddon: My Mom Just Posted a Youtube Video, at the annual convention of the Broadcast Education Association in April. The presentation discusses YouTube as a platform for media creators and encourages broadcast faculty members to become unconventional in their teaching, curriculum and course creation.

Also presenting at the BEA convention in Las Vegas are:

Jason Shepard, chair and associate professor of communications, was a presenter at the Free Speech and Open Inquiry on Campus conference at Chapman University Saturday, Feb. 25. Shepard discussed how to involve students in free speech advocacy on college campuses.

Human communication studies majors Joseph Fontana and Joseph Leung presented their research study, Does Your Coach Affect You? An Exploration of the Influences of Coaches Communication Styles on Team Sports Players at the Western States Communication Associations 2017 Undergraduate Scholars Research Conference in Salt Lake City. The two seniors conducted the research under the guidance of Tara Suwinyattichaiporn, assistant professor of human comminication studies, while enrolled in Suwinyattichaiporns Quantitative Research Methods course.

Link:
Exploring Bioengineering and Communication Faculty and Students Present, Discuss Research - CSUF News

Decoding the Genome’s Cryptic Language – Bioscience Technology

Bioengineers at the University of California San Diego have developed a new tool to identify interactions between RNA and DNA molecules. The tool, called MARGI (Mapping RNA Genome Interactions), is the first technology that's capable of providing a full account of all the RNA molecules that interact with a segment of DNA, as well as the locations of all these interactions -- in just a single experiment.

RNA molecules can attach to particular DNA sequences to help control how much protein these particular genes produce within a given time, and within a given cell. And by knowing what genes produce these regulatory RNAs, researchers can start to identify new functions and instructions encoded in the genome.

"Most of the human genome sequence is now known, but we still don't know what most of these sequences mean," said Sheng Zhong, bioengineering professor at the UC San Diego Jacobs School of Engineering and the study's lead author. "To better understand the functions of the genome, it would be useful to have the entire catalog of all the RNA molecules that interact with DNA, and what sequences they interact with. We've developed a tool that can give us that information."

Zhong and his team published their findings in the February issue of Current Biology.

Existing methods to study RNA-DNA interactions are only capable of analyzing one RNA molecule at a time, making it impossible to analyze an entire set of RNA-DNA interactions involving hundreds of RNA molecules.

"It could take years to analyze all these interactions," said Tri Nguyen, a bioengineering Ph.D. student at UC San Diego and a co-first author of the study.

Using MARGI, an entire set of RNA-DNA interactions could be analyzed in a single experiment that takes one to two weeks.

The MARGI technique starts out with a mixture containing DNA that's been cut into short pieces and RNA. In this mixture, a subset of RNA molecules are interacting with particular DNA pieces. A specially designed linker is then added to connect the interacting RNA-DNA pairs. Linked RNA-DNA pairs are selectively fished out, then converted into chimeric sequences that can all be read at once using high-throughput sequencing.

Zhong and his team tested the method's accuracy by seeing if it produced false positive results. First, the researchers mixed RNA and DNA from both fruit fly and human cells, creating both "true" RNA-DNA pairs, meaning they're either fully human or fully fruit fly, and "false" RNA-DNA pairs, meaning they're half human and half fruit fly -- these are the ones that shouldn't be detected. The team then screened the entire mixture using MARGI. The method detected a large set of true RNA-DNA interactions, but it also detected approximately 2 percent of the false ones.

"This method is not perfect, but it's an important step toward creating a full functional annotation of the genome," said co-first author Bharat Sridhar, a visiting bioengineering researcher in Zhong's group.

View post:
Decoding the Genome's Cryptic Language - Bioscience Technology

‘Grey’s Anatomy’ 3/2/2017 Why Didn’t the Show Air? – Closer … – Closer Weekly


Closer Weekly
'Grey's Anatomy' 3/2/2017 Why Didn't the Show Air? - Closer ...
Closer Weekly
Many #TGIT fans were totally confused last night when a new episode of Grey's didn't air on ABC on Thursday, March 2. Thankfully, it wasn't a TV glitch the hit ...
'Grey's Anatomy' Season 13 Episode 15 Spoilers Tease Meredith's ...Counsel & Heal
Gray's Anatomy Season 13: Episode 15, when will it be broadcast ...The Siver Times
Grey's Anatomy S13E16 Who Is He (And What Is He to You): April ...Unreality TV

all 6 news articles »

Read more:
'Grey's Anatomy' 3/2/2017 Why Didn't the Show Air? - Closer ... - Closer Weekly